Broadstreet in Vienna
Broadstreet is heading to Vienna for this year’s ISPOR Europe conference, November 6th to 9th. We are looking forward to warming up in some of the city’s famous coffee houses,…
Broadstreet is heading to Vienna for this year’s ISPOR Europe conference, November 6th to 9th. We are looking forward to warming up in some of the city’s famous coffee houses,…
Qualitative research methods have the potential to provide in-depth insights into the patient experience. They can also help us understand better the context in which medical interventions will be implemented…
The 2022 conference of the International Society for Pharmacoepidemiology (ICPE) will be held this week in Copenhagen, Denmark and Broadstreet is pleased to be presenting three posters regarding our work…
Broadstreet is pleased to be presenting several virtual posters at this year’s ISPOR meeting. VISUALIZING NETWORK META-ANALYSES IS NOT TRIVIAL – A NOVEL TAKE ON THE NETWORK DIAGRAM Popoff, E;1…
As life finally (hopefully!) begins to return to normal, over two years since the beginning of the pandemic, now seems like a good moment to reflect a bit on the…
Cost-effectiveness analyses and indirect treatment comparisons are important areas of health economics and outcomes research and when conducting these analyses, individual patient data (IPD) can provide valuable insight. Often, however,…
With 2021 having drawn to a close, we thought we would take the opportunity to look back on what has been another successful year for Broadstreet. Of course, the pandemic…
As another busy and productive year draws to a close here at Broadstreet, we wanted to take a few minutes to wish our friends, clients and colleagues a safe and…
Early clinical successes are becoming more common in oncology; and as a result, there is a need for endpoints that can meaningfully describe outcomes among treated patients. In cases where…
Broadstreet is pleased to be presenting several posters at this year’s virtual ISPOR Europe meeting. USE OF REAL-WORLD EVIDENCE TO EVALUATE INFLIXIMAB BIOSIMILARS: A SCOPING REVIEW Antoinette Cheung,1 Lauren Powell,1…